Zurück zu Projekte

18366.1 PFLS-LS

Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis

Zusammenfassung

Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis

Weitere Texte

Abstract

This feasibility project presents a lead peptide with promising anti-biofilm properties, which we aim to develop|into a drug candidate for the treatment of Pseudomonas infection in cystic fibrosis (CF) patients. The novel|mechanism of action utilized by this drug would create a niche in the CF drug market. The intellectual property|(IP) arising from this project will serve as the basis for the establishment of a company and further|development to bring the drug to the market.

Beteiligte

Urs Jenal

Kontaktperson

urs.jenal@unibas.ch

Universität Basel Biozentrum Urs Jenal Spitalstrasse 41 4056 Basel BS CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2016-01-31
Enddatum
2017-07-31
Bewilligte Gesamtkosten
CHF 352698.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%